Peihua Lu, Yong-xian Hu, Xian Zhang, Junfang Yang, Xiaoyu Zhu, Ying Wang, Keshu Zhou, Sanbin Wang, Jiang Cao, Heng Mei, Kai Hu, Yong Yu, Yali Zhou, Eileen McNulty, Ming Gao, Maria Delrosario, Wengang Ge, Yajin Ni, Jiangtao Ren, Jan Davidson-Moncada, He Huang. "CTD402, allogeneic anti-CD7 CAR t-cell, in relapsed or refractory (R/R) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL) - report of clinical outcomes at the recommended phase 2 dose (RP2D)." Blood, 2025. doi:10.1182/blood-2025-1042